The use of adjunctive GPIIb/IIIa inhibitors in patients with unstable angina/non-Q-wave MI undergoing percutaneous coronary intervention

By Salame Mahomed Y   More Ranjit S   Verheye Stefan   Leimbach Mark E   III Spencer B King   Chronos Nicolas AF  

International Journal of Cardiovascular Interventions, Vol. 2, Iss. 4, 1999-01 ,pp. : 207-215

Informa Healthcare

Access to resources Recommend Favorite

Oral Antiplatelet Efficacy of the Platelet GPIIb/IIIa Antagonist, DMP754 in Non-Human Primates - Receptor binding affinity & specificity

By Mousa S.A.   Bozarth J.   Youssef A.   Levine B.  

Thrombosis Research, Vol. 89, Iss. 5, 1998-03 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite

Platelet GPIIb/IIIa Receptor Antagonists in Human Ischemic Brain Disease

By  

Current Vascular Pharmacology, Vol. 6, Iss. 1, 2008-01 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

Intranasal Antiplatelet/ Antithrombotic Efficacy of a Novel Platelet GPIIB/IIIA Receptor Antagonist DMP755 - a model for in vivo evaluation of antithrombotic agents

By Mousa S.A.   Mu D.-X.   Hussain M.A.  

Thrombosis Research, Vol. 92, Iss. 3, 1998-11 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic arg-gly-asp peptide

By Tsao P.W.   Bozarth J.M.   Jackson S.A.   Forsythe M.S.   Flint S.K.   Mousa S.A.  

Thrombosis Research, Vol. 77, Iss. 6, 1995-03 ,pp. : 543-556

Elsevier

Access to resources Recommend Favorite